Gynecologic OncologyRobert F. Ozols Springer Science & Business Media, 2013 M03 14 - 387 páginas In recent years, there have been major advances in the treatment of patients with gynecologic malignancies. Perhaps the biggest advances have been in the area of ovarian cancer. Gynecologic Oncology focuses primarily upon this malignancy. This volume discusses cytoreductive surgery; screening for ovarian cancer; chemotherapy; new chemotherapeutic drugs; the controversy regarding the role of high-dose chemotherapy in gynecologic cancers; the hereditary basis for gynecologic malignancies; molecular genetics; molecular biology and new biologic therapies. Other topics covered are the treatment of all stages of cervical cancer, including radiotherapy. In addition, a chapter on advances in the pathology of gynecologic cancers is included. The advances made in the treatment of gynecologic malignancies are due, in part, to the clinical studies performed by many of the contributors to this volume. Clinical advances have been the result of multidisciplinary approaches which involve molecular biologists, pathologists, radiation therapists, surgeons and chemotherapists. Future advances will continue to rely upon collaborative interaction among these different disciplines. |
Contenido
Molecular Biology of Gynecologic Malignancies | 103 |
Biological Therapy for Gynecologic Malignancies | 115 |
Advances in the Treatment of Cervical Cancer | 149 |
5 | 168 |
MORTON and GILLIAN M THOMAS | 177 |
IVOR BENJAMIN and STEPHEN C RUBIN | 202 |
Chemotherapy of Ovarian Cancer | 219 |
Role of Operative Laparoscopy in Gynecologic Oncology | 235 |
HighDose Chemotherapy in Gynecologic Malignancies | 277 |
Advances in the Pathology of Gynecologic Cancer | 353 |
377 | |
Otras ediciones - Ver todas
Términos y frases comunes
abnormal adenocarcinoma advanced ovarian cancer analysis antigen associated BRCA1 BRCA2 breast cancer Cancer Res carboplatin cervical cancer cervical carcinoma chemotherapy chromosome cisplatin Clin Oncol clinical correlation cytometry cytoreductive surgery debulking detected DNA ploidy dose endometrial cancer endometrial carcinoma epithelial ovarian cancer evaluation expression flow cytometric gene germ cell tumors grade growth factor Gynecol Cancer Gynecol Oncol Gynecologic Oncology Group hereditary high-dose histologic human ovarian hysterectomy Int J Gynecol Int J Radiat intraperitoneal invasive laparoscopic laparotomy levels lymph node lymphadenectomy Lynch HT malignant markers metastases mg/m² molecular mutations neoplasia neoplasms Obstet Gynecol oncogene Oncol Biol Phys ovarian carcinoma ovarian tumors ovary overexpression paclitaxel para-aortic Pathol patients with ovarian pelvic ploidy prognostic factors prognostic significance protein Radiat Oncol Biol radiation therapy radiotherapy receptor recurrent reported residual disease risk screening second-look serum CA 125 survival syndrome testicular tissue toxicity treatment trophoblastic uterine cervix women